COVID-19 UPDATE:  At GW Pharmaceuticals, our main concern is the well-being of our patients, healthcare partners, and employees.
Read More

EPIDIOLEX® (cannabidiol) UPDATE:  The DEA has confirmed that EPIDIOLEX (cannabidiol) is no longer scheduled.
Learn More

  1. Home
  2. Home

Home

About Us

Girl Smiling

GW is the global leader in developing cannabinoid-based medicines.

READ MORE >

Healthcare Professionals

Boy and Mother Looking at Something

GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics.

READ MORE >

Patients & Caregivers

Girl Blowing Bubbles

"GW's vision is to be the global leader in prescription cannabinoid medicines, developing and commercializing pharmaceutical products which address clear unmet needs." >


-Justin Gover,
Chief Executive Officer

Investors & Media

Arlo and his mother

Click here to view Investors Relations section. >

Careers

Boy Looking at Something

Join GW Pharmaceuticals where you can positively impact the lives of patients. >

Recent News

Girl Blowing Bubbles
Apr 06, 2020
GW Pharmaceuticals plc and Its U.S. Subsidiary Greenwich Biosciences, Inc. Announce That EPIDIOLEX® (cannabidiol) Oral Solution Has Been Descheduled And Is No Longer A Controlled Substance
Read More >

Contact Us